• DOI:10.4172/2161-0460.1000434
Corpus ID: 44180505

Neuroinflammation in Preclinical Alzheimer's Disease: A Review of Current Evidence

@article{Watermeyer2018NeuroinflammationIP,
  title={Neuroinflammation in Preclinical Alzheimer's Disease: A Review of Current Evidence},
  author={Tamlyn J Watermeyer and V. Raymont and K. Ritchie},
  journal={Journal of Alzheimers Disease & Parkinsonism},
  year={2018},
  volume={8},
  pages={1-6}
}

• Tamlyn J Watermeyer, V. Raymont, K. Ritchie
• Published 2018
• Medicine
• Journal of Alzheimers Disease & Parkinsonism

The pathology of sporadic Alzheimer’s disease (AD) may be present at mid-life and precede the prodromal and clinical dementia syndromes associated with the disorder by decades. Few successful therapeutic treatments exist and, as a result, attention is turning to the preclinical stages of the disease for the development of future intervention strategies. The success of such strategies will rely on well-defined biomarkers of preclinical disease to identify and monitor changes earlier in the… Expand

View via Publisher

Save to Library

Create Alert

Cite

Launch Research Feed